UK drug regulator destroys all evidence after 15 yearsBMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d4203 (Published 05 July 2011) Cite this as: BMJ 2011;343:d4203
- Peter C Gøtzsche, professor and director1
- 1Nordic Cochrane Centre, Rigshospitalet, DK-2100 Copenhagen Ø, Denmark
Jørgensen and I recently gained access to clinical study reports and trial protocols of placebo controlled trials at the European Medicines Agency (EMA).1 Some drugs, however, have not been approved centrally, and in such cases the EMA advises contacting the relevant national drug agencies.
For the antidepressant drug fluoxetine, the United Kingdom acts as Reference Member State according to the Mutual Recognition …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial